Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Abstract: A communication method and apparatus using a network slice. A method of performing communication on a control plane of a network system including an access network and a core network may receive an attach request from a user equipment, may perform a mutual authentication with the user equipment in response to the attach request, may retrieve a subscription profile for the user equipment in response to the attach request, when the mutual authentication is completed, and may determine a network slice for the user equipment based on the subscription profile.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: Disclosed are a base station and a channel access method performing a channel access in a unlicensed band. The channel access method includes: performing channel sensing at least once on a channel of the unlicensed band in a channel sensing period of a frame; and broadcasting a reservation signal for the channel when the channel is empty.

Abstract: According to an exemplary embodiment of the present invention, a master base station selects a target serving cell in which a state is changed, among the serving cells of at least one slave base station set in the terminal, generates a MAC control element which instructs a state change of the target serving cell, and then directly transmits the MAC control element to the terminal in the case of an uplink asynchronous state between the target slave base station managing the target serving cell and the terminal.

Abstract: Disclosed herein are a method and an apparatus for configuring a radio resource. In a wireless communication system, a radio resource is split into a plurality of radio resource slices corresponding to different service types and a radio source slice corresponding to a service type among a plurality of radio resource slices that a device requests is determined.

Abstract: Disclosed herein is an ultrasound imaging apparatus for dividing obtained ultrasound image information into pieces of image information in units of regions of a human body, mapping a body marker to the pieces of image information corresponding to the body marker, and outputting a result of mapping the body marker to the pieces of image information; and a method of controlling the same. The ultrasound imaging apparatus includes an image processor configured to obtain image information from an object, a controller configured to divide the obtained image information into pieces of image information in units of regions of a human body and map a body marker to the pieces of image information corresponding to the body marker, and a user interface unit configured to output a result of mapping the body marker to the pieces of image information.

Abstract: A base station of a mobile communication system divides an ultra wideband into a plurality of unit bands, uses a plurality of beam component carriers corresponding to the L3 CP dedicated unit band as a coverage layer by grouping in one cell in the L3 CP dedicated unit band and uses a plurality of beam component carriers corresponding to the UP dedicated unit band in the UP dedicated unit band as a plurality of capacitor layers by grouping in a plurality of cells of a smaller size than that of the grouping.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: Disclosed is a mobile communication network system and a network configuring method. The communication network system includes: a common control access network; at least one access network slice added according to a service type requested by a device; a common control core network; and at least one core network slice added according to a service type requested by the device. The access network slice and the core network slice are determined by the service type requested by the device.

Abstract: The present invention relates to new uses of modified human tumor necrosis factor receptor-1 (TNFRI) polypeptide, and more particularly, to uses thereof for prevention and treatment of dry eye syndrome. The modified TNFRI or modified TNFRI fragment of the present invention has excellent TNF? neutralizing activity, and inhibits TNF? activity on the ocular surface of the patient to suppress inflammation induction effects related to dry eye. Therefore, the modified TNFRI or modified TNFRI fragment of the present invention exhibits remarkable effects in the prevention and treatment of dry eye syndrome, and thus can be very useful in the prevention and treatment of dry eye syndrome.

Abstract: A controlling a portable device comprising a first touch screen and a second touch screen is provided. The method includes displaying first information related to a first application on the first touch screen and displaying second information related to the first application on the second touch screen; receiving a first user input moving to the first touch screen on the second touch screen; and replacing the first information and the second information with a third information and a fourth information related to the first application on the first touch screen and the second touch screen, in response to receiving the first user input, wherein each of the third information and the fourth information is displayed while being slidden in direction from the second touch screen to the first touch screen and the third information is displayed over a boundary between the first touch screen and the second screen during the sliding of the third information and the fourth information.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: A UE does not immediately perform handover after receiving a handover command from a serving base station, but instead backups that message and continuously compares the signal strength of a serving base station and the signal strength of a target base station and performs a handover to the target base station at the best timing when handover is required. Once the timing of handover is determined, the UE transmits a handover indication message to the serving base station, and thereafter the UE performs a handover to the target base station.

Abstract: A method of controlling a portable device including at least one foldable panel and first and second touch screens is provided. The method includes displaying, on the first touch screen, a first page designated as a home screen and an icon related to at least one application, and a dock area, and displaying, on the second touch screen, first information in a state where the foldable panel is unfolded. The method also includes replacing the first page and the dock area with an outgoing call screen, receiving a phone number input, replacing the outgoing call screen with a dialing screen, and displaying, on the second touch screen, a guide message indicating to fold the portable device for a call. The method also includes replacing the dialing screen with a mid-call screen, and removing the guide message displayed on the second touch screen, and displaying the first information.

Abstract: A method of controlling a portable device including at least one foldable panel and first and second touch screens is provided. The method includes displaying, on the first touch screen, a first page designated as a home screen and an icon related to at least one application, and a dock area, and displaying, on the second touch screen, first information in a state where the foldable panel is unfolded. The method also includes replacing the first page and the dock area with an outgoing call screen, receiving a phone number input, replacing the outgoing call screen with a dialing screen, and displaying, on the second touch screen, a guide message indicating to fold the portable device for a call. The method also includes replacing the dialing screen with a mid-call screen, and removing the guide message displayed on the second touch screen, and displaying the first information.

Abstract: A method of controlling a portable device including at least one foldable panel and first and second touch screens is provided. The method includes displaying, on the first touch screen, a first page designated as a home screen and an icon related to at least one application, and a dock area, and displaying, on the second touch screen, first information in a state where the foldable panel is unfolded. The method also includes replacing the first page and the dock area with an outgoing call screen, receiving a phone number input, replacing the outgoing call screen with a dialing screen, and displaying, on the second touch screen, a guide message indicating to fold the portable device for a call. The method also includes replacing the dialing screen with a mid-call screen, and removing the guide message displayed on the second touch screen, and displaying the first information.